Arkolith/Insider Trading/ERNA/Form 4

Cherington Charles

10% OwnerErnexa Therapeutics Inc. (ERNA) · full profile →Form 4 · filed Feb 17, 2026
Net Buying
Open-Market Buys
$2.0M
Open-Market Sells
$0
Net Open-Market Flow
$2.0M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 10, 2026Buy(P)4.0M$0.50$2.0M6.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 10, 2026Buy(P)4.0M——4.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-016680) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML